Pavmed INC. (PAVM) — DEF 14A Filings

All DEF 14A filings from Pavmed INC.. Browse 4 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (4)

PAVmed Seeks Reverse Split to Boost Share Price, Avoid Nasdaq Delisting — Oct 31, 2025 Risk: high
PAVmed Inc. (PAVM) is seeking stockholder approval for a reverse stock split at a ratio between 1-for-10 and 1-for-30, along with a reduction in authorized comm
PAVmed Inc. DEF 14A: Executive Compensation Details — Apr 30, 2025 Risk: medium
PAVmed Inc. filed a DEF 14A on April 30, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on
PAVmed Inc. Files Definitive Proxy Statement — Dec 6, 2024 Risk: low
PAVmed Inc. filed its definitive proxy statement (DEF 14A) on December 6, 2024, for its fiscal year ending December 31, 2024. The filing, which is not subject t
PAVmed Inc. Announces Annual Meeting of Stockholders on June 20, 2024 — Apr 29, 2024 Risk: low
PAVmed Inc. (PAVM) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. PAVmed Inc. will hold its Annual Meeting of Stockholders on June 20, 2024,

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX